Identification of a 7-cM region of frequent allelic loss on chromosome band 16p13.3 that is specifically associated with anaplastic thyroid carcinoma

Oncology Reports

Volumn 7, Issue 3, 2000, Pages 529-533

  Kadota, Masao ^a   Tamaki, Yasuhiro ^a   Sakita, Isao ^a   Komoike, Yoshifumi ^a   Miyazaki, Michihiko ^a   Ooka, Masaru ^a   Masuda, Norikazu ^a   Fujiwara, Yoshiyuki ^a   Ohnishi, Tadashi ^a   Tomita, Naohiro ^a   Sekimoto, Mitsugu ^a   Ohue, Masayuki ^a   Ikeda, Takayuki ^c   Kobayashi, Tetsuro ^b   Horii, Akira ^c   Monden, Morito ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b IKEDA MUNICIPAL HOSPITAL   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anaplastic thyroid cancer; Anaplastic transformation; Loss of heterozygosity

Indexed keywords

MICROSATELLITE DNA;

ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOMA; CHROMOSOME 16; CHROMOSOME MAP; FEMALE; GENETIC MARKER; GENETICS; HETEROZYGOSITY LOSS; HUMAN; MIDDLE AGED; PAPILLARY CARCINOMA; PATHOLOGY; SECOND CANCER; THYROID TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CARCINOMA, PAPILLARY; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 16; FEMALE; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; THYROID NEOPLASMS;

EID: 0034185891     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.7.3.529     Document Type: Article

References (25)

1. Venkatesh YSS, Ordonez NG, Schultz PN, Hickey RC, Goepfert H and Samaan NA: Anaplastic carcinoma of the thyroid. Cancer 66: 321-330, 1990.
2. Rosai J and Carcangiu ML: Pathology of thyroid tumors. Some recent and old questions. Hum Pathol 15: 1008-1012, 1984.
3. Nakamura T, Yana I, Kobayashi T, Shin E, Karakawa K, Fujita S, Miya A, Mori T, Nishisho I and Takai S: p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas. Jpn J Cancer Res 83: 1293-1298, 1992.
4. Komoike Y, Tamaki Y, Sakita I, Tomita N, Ohue M, Sekimoto M, Miyazaki M, Kadota M, Masuda N, Ooka M, Ohnishi T, Nakano Y, Kozaki T, Kobayashi T, Matsuura N, Ikeda T, Horii A and Monden M: Comparative genomic hybridization defines frequent loss on 16p in human anaplastic thyroid carcinoma. Int J Oncol 14: 1157-1162, 1999.
5. Ohue M, Tomita N, Monden T, Miyoshi Y, Ohnishi T, Izawa H, Kawabata Y, Sasaki M, Sekimoto M, Nishisho I, Shiozaki H and Monden M: Mutations of the transforming growth factor β type II receptor gene and microsatellite instability in gastric cancer. Int J Cancer 68: 203-206, 1996.
6. Namba H, Gutman RA, Matsuo K, Alvarez A and Fagin JA: H-ras protooncogene mutations in human thyroid neoplasms. J Clin Endocrinol Metab 71: 223-229, 1990.
7. Suarez HG, Villard JA, Severino M, Caillou B, Schlumberger M, Tubiana M, Parmentier C and Monier R: Presence of mutations in all three ras genes in human thyroid tumors. Oncogene 5: 565-570, 1990.
8. Mulligan LM, Kwok JBJ, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenius H, Tunnacliffe A and Ponder BA: Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363: 458-460, 1993.
9. Santoro M, Dathan NA, Berlingieri MT, Bongarzone I, Paulin C, Grieco M, Pierotti MA, Vecchio G and Fusco A: Molecular characterization of RET/PTC3: a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma. Oncogene 9: 509-516, 1994.
10. Sugg SL, Ezzat S, Zheng L, Freeman JL, Rosen IB and Asa SL: Oncogene profile of papillary thyroid carcinoma. Surgery 125: 46-52, 1999.
11. Matias-Guiu X, Villanueva A, Cuatrecasas M, Capella G, Leiva AD and Prat J: p53 in a thyroid follicular carcinoma with foci of poorly differentiated and anaplastic carcinoma. Path Res Pract 192: 1242-1249, 1996.
12. Levine AJ, Monad J and Finlay CA: The p53 tumor suppressor gene. Nature 351: 453-456, .
13. Califano JA, Johns MM III, Westra WH, Lango MN, Eisele D, Saji M, Zeiger MA, Udelsman R, Koch WM and Sidransky D: An allelotype of papillary thyroid cancer. Int J Cancer 69: 442-444, 1996.
14. Grebe SKG, Mciver B, Hay ID, Wu PSC, Maciel LMZ, Drabkin HA, Goellner JR, Grant CS, Jenkins RB and Eberhardt NL: Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma. J Clin Endoclinol Metab 82: 3684-3691, 1997.
15. Zhang JS, Nelson M, Mciver B, Hay ID, Goellner JR, Grant CS, Eberhardt NL and Smith DI: Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors. Oncogene 17: 789-793, 1998.
16. Lininger RA, Park WS, Man YG, Pham T, MacGrogan G, Zhuang Z and Tavassoli FA: LOH at 16p13 is a novel chromosomal alteration detected in benign and malignant microdissected papillary neoplasms of the breast. Hum Pathol 29: 1113-1118, 1998.
17. Suzuki K, Ogura T, Yokose T, Nagai K, Mukai K, Kodama T, Nishiwaki Y and Esumi H: Loss of heterozygosity in the tuberous sclerosis gene associated regions in adenocarcinoma of the lung accompanied by multiple atypical adenomatous hyperplasia. Int J Cancer 79: 384-389, 1998.
18. Takei K, Kohno T, Hamada K, Takita J, Noguchi M, Matsuo Y, Hirohashi S, Uezato H and Yokota J: A novel tumor suppressor locus on chromosome 18q involved in the development of human lung cancer. Cancer Res 58: 3700-3705, 1998.
19. Martinez LE, Abad A, Font A, Monzo M, Ojangueren I, Pifarre A, Sanchez JJ, Martin C and Rosell R: Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer. Gastroenterology 114: 1180-1187, 1998.
20. Huiping C, Eiriksdottir G, Sigurdsson A, Sigurgeirsdottir JR, Barkardottir RB, Egilsson V and Ingvarsson S: High frequency of LOH at chromosome 18q in human breast cancer: association with high S-phase fraction and low progesterone receptor content. Anticancer Res 18: 1031-1036, 1998.
21. Inoue T, Uchino S, Shiraishi N, Adachi Y and Kitano S: Loss of heterozygosity on chromosome 18q in cohensive-type gastric cancer is associated with tumor progression and poor prognosis. Clin Cancer Res 4: 973-977, 1998.
22. Pearlstein RP, Benninger MS, Carey TE, Zarbo RJ, Torres FX, Rybicki BA and Dyke DL: Loss of 18q predicts poor survival of patients with squamous cell of the head and neck. Genes Chromosomes Cancer 21: 333-339, 1998.
23. Ueda T, Komiya A, Emi M, Suzuki H, Shiraishi T, Yatani R, Masai M, Yasuda K and Ito H: Allelic losses on 18q21 are associated with progression and metastasis in human prostate cancer. Genes Chromosomes Cancer 20: 140-147, 1997.
24. Frank CJ, McClatchey KD, Devaney KO and Carey TE: Evidence that loss of chromosome 18q is associated with tumor progression. Cancer Res 57: 824-827, 1997.
25. Dib C, Faur S, Fizames C: A comprehensive genetic map of the human genome based on 5264 microsatellites. Nature 380: 152-154, 1996.